Furthermore, CA treatment contributed to inhibiting proliferation and metastasis while stimulating apoptosis in various CRC cell lines via the NF-κB pathway (Tyagi et al., 2017; Buhrmann et al., 2019; Buhrmann et al., 2020b). Here, NFKB1 is linked to colorectal carcinoma.